Fundraising FoxVeiltherapeutics
1 known investors
Find your way into Veiltherapeutics
Sign up to see every warm intro you have to Veiltherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Veiltherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Veil Therapeutics develops "stealth biologics" using a PEG-based bottlebrush polymer platform (the Veil Platform) designed to extend drug half-life and stability while evading immune recognition. Its lead program, VTx-101, is a polymer-conjugated uricase for treating chronic gout, with the platform also applicable to proteins, peptides, lipid nanoparticles, and aptamers.
Founders & leadership
RH
Ryan HallettCEO
AH
Angus HucknallFounder
AC
Ashutosh ChilkotiChairman & Founder
PS
Parul SirohiHead of Research
Investors · 1
Frequently asked questions
- What does Veiltherapeutics do?
- Veil Therapeutics develops "stealth biologics" using a PEG-based bottlebrush polymer platform (the Veil Platform) designed to extend drug half-life and stability while evading immune recognition. Its lead program, VTx-101, is a polymer-conjugated uricase for treating chronic gout, with the platform also applicable to proteins, peptides, lipid nanoparticles, and aptamers.
- Who are Veiltherapeutics's investors?
- Veiltherapeutics's investors include Medblue.